Halper Sadeh investigates Sonnet BioTherapeutics, First Community Corp, Monogram Technologies mergers.

Halper Sadeh LLC is investigating potential securities violations and fiduciary breaches in three companies: Sonnet BioTherapeutics' merger with Rorschach I LLC, First Community Corporation's merger with Signature Bank of Georgia, and Monogram Technologies Inc.'s sale to Zimmer Biomet Holdings. Shareholders are encouraged to click on the respective links to learn more about their legal rights and options.

Halper Sadeh LLC, a prominent investor rights law firm, has initiated investigations into potential securities violations and fiduciary breaches in three companies: Sonnet BioTherapeutics' merger with Rorschach I LLC, First Community Corporation's merger with Signature Bank of Georgia, and Monogram Technologies Inc.'s sale to Zimmer Biomet Holdings. Shareholders are encouraged to click on the respective links to learn more about their legal rights and options.

Sonnet BioTherapeutics' Merger with Rorschach I LLC

Halper Sadeh LLC is examining whether the merger of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) and Rorschach I LLC is fair to Sonnet shareholders. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company [1]. The investigation focuses on whether Sonnet and its board violated federal securities laws and breached their fiduciary duties by failing to obtain the best possible consideration for shareholders and disclose all material information necessary for adequate assessment and valuation of the merger consideration.

First Community Corporation's Merger with Signature Bank of Georgia

The law firm is also investigating the merger of First Community Corporation (NASDAQ: FCCO) and Signature Bank of Georgia. Halper Sadeh LLC is assessing whether First Community and its board violated federal securities laws and breached their fiduciary duties by failing to obtain the best possible consideration for shareholders and disclose all material information necessary for adequate assessment and valuation of the merger consideration [3].

Monogram Technologies Inc.'s Sale to Zimmer Biomet Holdings

Additionally, Halper Sadeh LLC is investigating the sale of Monogram Technologies Inc. (NASDAQ: MGRM) to Zimmer Biomet Holdings, Inc. The investigation concerns whether Monogram and its board of directors violated federal securities laws and breached their fiduciary duties by failing to obtain the best possible consideration for shareholders, determine whether Zimmer is underpaying for Monogram, and disclose all material information necessary for adequate assessment and valuation of the merger consideration [5].

Shareholders are urged to contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or via email at sadeh@halpersadeh.com or zhalper@halpersadeh.com to learn more about their legal rights and options. Halper Sadeh LLC will handle these actions on a contingent fee basis, ensuring shareholders are not responsible for out-of-pocket legal fees or expenses.

References:
[1] https://www.businesswire.com/news/home/20250714417363/en/SONN-Stock-Alert-Halper-Sadeh-LLC-Is-Investigating-Whether-the-Merger-of-Sonnet-BioTherapeutics-Inc.-Is-Fair-to-Shareholders
[3] https://www.businesswire.com/news/home/20250714230210/en/FCCO-Stock-Alert-Halper-Sadeh-LLC-is-Investigating-Whether-the-Merger-of-First-Community-Corporation-is-Fair-to-Shareholders
[5] https://www.businesswire.com/news/home/20250714146347/en/MGRM-Stock-Alert-Halper-Sadeh-LLC-Is-Investigating-Whether-the-Sale-of-Monogram-Technologies-Inc.-Is-Fair-to-Shareholders